On November 4, 2024, Martin Gepsman, a Director at CME Group Inc (CME, Financial), sold 400 shares of the company at a price of $222.92 per share. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 25,067 shares of CME Group Inc.
CME Group Inc operates the world's largest financial derivatives exchange, allowing investors to trade futures and options on various asset classes, including commodities, currencies, and stock indices.
Over the past year, the insider transaction history at CME Group Inc shows a trend with 5 insider buys and 17 insider sells. Specifically, Martin Gepsman has sold a total of 400 shares and has not made any purchases in the same period.
Shares of CME Group Inc were trading at $222.92 on the day of the sale, giving the company a market cap of approximately $80.33 billion. The price-earnings ratio of the stock stands at 23.46, which is above the industry median of 18.475.
The stock's valuation according to the GF Value is $233.80, indicating a price-to-GF-Value ratio of 0.95. This suggests that CME Group Inc is Fairly Valued based on its GF Value, which considers historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates.
This insider sale might interest investors tracking insider behaviors as an indicator of the company's future performance and valuation alignment.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
